ARWR
ARROWHEAD PHARMA
Health Care·Biotechnology·UNITED STATES
$73.33
MCap $10.3B
as of 2026-06-09
Total
C1w
Fund
D1w
Quant
A1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-06-10
MIDOS SI
+0.10
Sentiment 34.6%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$73.33
Adaptive Mean
$73.12
+0.21 vs mean
Adaptive σ
1.07
MIDOS BB
$70.98 – $75.25
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-05-15
Composite Z
-0.15
ROE
-46.4%
Z -0.54
Rev Gr
-86.4%
Z -0.98
EPS Gr
99.8%
Z +0.31
OPM Gr
—
Z —
FCF Yld
-0.5%
Z +0.05
EPS Surp
14.9%
Z +0.06
EPS 3mo Δ
2.7%
Z +0.21
Fwd P/E
-16.90
Z —
PEGY
-0.17
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-06-10
Q3M
3.36
Q6M
2.62
Q12M
10.79
MA 30/100
1.119
Bullish (MA30 > MA100)
α (Jensen)
0.3497
β (12M)
1.65
σ (12M)
0.651
Divergence — Fundamentals vs Momentum
Z Percentile
24%
Q Percentile
98%
Divergence
-74.5
Tier
TRIM — ACT
Momentum well ahead of fundamentals. Trim candidate.
Kirkpatrick RS & Persistence
RS
18.4
RS Pctl
73%
RS Decile
D8
Persistence
1w
at grade C
Options / OI Analysis
as of 2026-06-10
OI Center
$74.32
+1.4% from spot
Max Pain
$70.00
PCR (OI)
0.71
neutral
Skew
-0.06
OI Composite
0
neutral
Direction
neutral